Summary
Glucocerebroside β-glucosidase (glucocerebrosidase) activity was assayed from cultured fibroblasts of normal individuals, and patients with type 1 (non-neuropathic), type 2 (acute neuropathic), and type 3 (subacute neuropathic) form of Gaucher disease. Residual glucocerebrosidase activity of patients was 8.9 to 17.4% of normal controls, and there was no clear correlation between the level of residual enzyme activity and the different clinical subtypes of the disease. When membrane-bound glucocerebrosidase activity was assayed in the presence of crude brain lipid extracts or purified phosphatidylserine, enzyme from both the normal and type 1 Gaucher fibroblasts was stimulated dramatically (35–60% by crude extracts, 85–90% by phosphatidylserine). This stimulation was not observed with fibroblast glucocerebrosidase of an infantile type 2 and two juvenile type 3 Gaucher patients. The presence of inhibitors of glucocerebrosidase in these type 2 and type 3 Gaucher cells was not detected. Contrary to the mutant enzyme from these Gaucher fibroblasts, glucocerebrosidase from fibroblasts of two adult type 3 Gaucher patients with cerebral involvement was stimulated substantially (72–85%) by phosphatidylserine. When membrane-bound glucocerebrosidase from fibroblasts of the infantile type 2 and juvenile type 3 patients was solubilized with sodium cholate (1% w/v) and delipidated, the phospholipid stimulation of enzyme activity was restored. These findings suggest that considerable clinical and biochemical heterogeneity exists among patients with neuropathic Gaucher disease and that phosphatidylserine activation cannot be used as a reliable indicator in predicting future onset of neurodegeneration in Gaucher patients. The possibility of an aberrant binding of mutant glucocerebrosidase to the lysosomal membrane in juvenile type 3 form of Gaucher disease is discussed.
Similar content being viewed by others
References
Ben-Yoseph Y, Nadler HL (1978) Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease. J Clin Pathol 31: 1091–1093
Beutler E (1977) Gaucher's disease in an asymptomatic 72-year-old. JAMA 237:2529
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindings. Anal Biochem 72:248–254
Brady RO, Barranger JA (1983) Glucosylceramide lipidosis: Gaucher disease. In: Stanbury JB, Wyngaarden DS, Frederickson DS, Goldstein JL (eds) Metabolic basis of inherited disease, 5th edn. McGraw-Hill, New York, pp 842–856
Brady RO, Kanfer JN, Shapiro D (1965) Metabolism of glucocerebrosidase. II. Evidence of enzymatic deficiency in Gaucher's disease. Biochem Biophys Res Commun 18:221–225
Brady RO, Kanfer JN, Bradley RM, Shapiro D (1966) Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher disease. Clin Invest 45:1112
Chiao YB, Hoyson GM, Peters SP, Lee RE, Diven W, Murphy JV, Glew RH (1978) Multiple glycosidase deficiencies in a case of juvenile (type 3) Gaucher disease. Proc Natl Acad Sci USA 75: 2448–2452
Choy FYM (1981) Gaucher disease: differential stimulation of residual glucocerebrosidase activity by phospholipids in type 1 and type 2 Gaucher fibroblasts. Am J Hum Genet 33:39A
Choy FYM, Davidson RG (1978) Gaucher's disease. I. Solubilisation and electrophoresis of β-glucosidase from leukocytes and cultured fibroblasts. Pediatr Res 12:1115–1120
Choy FYM, Davidson RG (1980a) Gaucher's disease. II. Studies on the kinetics of β-glucosidase and the use of nonlabelled natural substrates for the investigation of patients. Pediatr Res 14:54–59
Choy FYM, Davidson RG (1980b) Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabelled natural substrates for the investigation of patients Am J Hum Genet 32:670–680
Choy FYM, Davidson RG (1982) Qualitative characteristics of the β-glucosidase isozymes. In: Desnick RJ, Gatt S, Grabowski GA (eds) Gaucher disease: a century of delineation and research. Alan R Liss Inc, New York, pp 415–441
Dale GL, Beutler E (1976) Enzyme replacement therapy in Gaucher's disease. A rapid, high-yield method for purification of glucocerebrosidase. Proc Natl Acad Sci USA 73:4672
Ginns EI, Brady RO, Pirrucello S, Moore C, Sorrel S, Furbish FS, Murray GJ, Tages JM, Barranger JA (1982) Mutations of glucocerebrosidase: Discrimination of neurologic and non-neurologic phenotypes of Gaucher's disease. Proc Natl Acad Sci USA 79: 5607–5610
Glew RH, Daniels LB, Clark LS, Hoyer SW (1982) Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease. J Neuropathol Exp Neurol 41:630–641
Halliday N, Dennel HG Jr, Tragerman LJ, Ward WE (1940) On the isolation of a glucose-containing cerebroside from spleen in a case of Gaucher's disease. J Biol Chem 132:171–180
Ho MW, Light D (1973) Glucocerebrosidase: reconstitution from macro-molecular components depends on acidic phospholipids. Biochem J 136:821–823
Mattoth Y, Zaizov R, Hoffman J, Klibansky C (1974) Clinical and biochemical aspects of chronic Gaucher disease. Isr J Med Sci 10:1523–1527
Mueller OT, Rosenberg A (1977) β-Glucosidase hydrolase of normal and glucosylceramidotic cultured human skin fibroblasts. J Biol Chem 252:825–829
Owada M, Sakiyama T, Kitogawa T (1977) Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-β-glucosidase activity in the liver. Pediatr Res 11:641–646
Peters SP, Glew RH, Lee RE (1977) Gaucher disease. In: Glew RH Peters SP (eds) Practical enzymology of the sphingolipidosis, 1st edn. Alan R Liss, New York, pp 72–97
Rosenberg A, Chargaff E (1956) A reinvestigation of the cerebroside deposited in Gaucher's disease. J Biol Chem 233:1323
Strasberg PM, Lowden JA, Mahuran D (1982) Purification of glucosylceramidase by affinity chromography. Can J Biochem 60: 1025–1031
Turner BM, Beratis NG, Hirschhorn K (1977) Cell-specific differences in membrane β-glucosidase from normal and Gaucher cells. Biochim Biophys Acta 480:442–449
Wenger DA, Olson GC (1981) Heterogeneity in Gaucher disease. In: Callahen JW, Lowden JA (eds) Lysosomes and lysosomal storage diseases. Raven Press, New York, pp 157–171
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Choy, F.Y.M. Gaucher disease: The effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts. Hum Genet 67, 432–436 (1984). https://doi.org/10.1007/BF00291405
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00291405